Therapeutics Research Working Group (TRWG)
Mission
The NIH AIDS therapeutics portfolio includes a broad range of research efforts from basic drug discovery and drug development through clinical efficacy trials. The Therapeutics Research Working Group (TRWG) will assist the OAR and the NIH in the following activities:
- identifying scientific opportunities and priorities as well as program gaps in drug discovery and development, pre-clinical testing, and clinical trials of potential drugs and treatment regimens;
- working with NIH staff on the Therapeutics Coordinating Committee in developing the Therapeutics section of the annual NIH Plan for HIV-Related Research; and
- providing periodic updates on the AIDS therapeutics research agenda to the OAR Advisory Council (OARAC).
Administration
TRWG members will be appointed by the OAR Director and chaired by an OARAC member with expertise in either drug discovery or clinical trials research. TRWG members will include representatives from academia, industry, and community constituency groups. The Chair of the OAR Therapeutics Coordinating Committee will staff the TRWG and serve as its Executive Secretary.
Current Members
Michael S. Saag, M.D.
Chair
University of Alabama at Birmingham
Ms. Dawn Averitt Bridge
Yvonne J. Bryson, M.D.
University of California Los Angeles
School of Medicine
Thomas R. Fleming, Ph.D.
University of Washington
Craig W. Hendrix, M.D.
Johns Hopkins University Medical Center
Randi Y. Leavitt, M.D., Ph.D.
Merck Research Laboratories
Judy Lieberman, M.D., Ph.D.
Harvard University
CBR Institute for Biomedical Research
Dennis C. Liotta, Ph.D.
Emory University
Douglas J. Manion, M.D., F.R.C.P.
Pharmaceutical Research Institute
Bristol-Myers Squibb Company
Michele V. McNeill, Pharm.D.
Thomas Quinn, M.D.
Johns Hopkins University
Michael Simberkoff, M.D.
Manhattan Veterans Affairs Medical Center
New York University School of Medicine
Melanie A. Thompson, M.D.
AIDS Research Consortium of Atlanta, Inc.
Jeffrey Nadler, M.D.
NIAID Liaison
Division of AIDS
Robert W. Eisinger, Ph.D.
Executive Secretary
Chair, Therapeutics Coordinating Committee
OAR Therapeutics Research Coordinator